NACDS Leadership Details NACDS’ Value for Industry Transformation DIR fee reform, health-and-wellness expansion top Business Program agenda; NACDS communicates from Denver to Washington, D.C. about trade war’s risks

2018-09-05T09:07:19+00:00Aug-26-18|Categories: Press Release|Tags: , , , , , , , |

DIR fee reform, health-and-wellness expansion top Business Program agenda; NACDS communicates from Denver to Washington, D.C. about trade war’s risks.

NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

2018-07-18T16:25:32+00:00Jul-18-18|Categories: Press Release|Tags: , , , , |

NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

2018-07-11T12:20:12+00:00Jul-11-18|Categories: Press Release|Tags: , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).

NACDS Lauds Congress’ Call for DIR Fee Reform Led by Reps. Marino and Loebsack, House letter to HHS Secretary Azar describes reforms needed to reduce beneficiary cost-sharing and to boost health outcomes

2018-05-10T08:44:31+00:00Apr-20-18|Categories: Press Release|Tags: , , |

NACDS hailed a letter to Health and Human Services Secretary Alex Azar in support of achieving pro-patient and pro-pharmacy reforms of direct and indirect remuneration (DIR) fees in Medicare Part D.